AI Analysis AI Analysis of BLRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BLRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Green day on Thursday for BioLineRx Ltd. stock after gaining 2.41%
(Updated on Jul 16, 2026)

Sell candidate since Jul 06, 2026 Loss -5.61%

The BioLineRx Ltd. stock price gained 2.41% on the last trading day (Thursday, 16th Jul 2026), rising from $2.91 to $2.98. During the last trading day the stock fluctuated 5.86% from a day low at $2.90 to a day high of $3.07. The price has risen in 5 of the last 10 days but is still down by -5.99% for this period. Volume fell on the last day by -1 thousand shares and in total, 7 thousand shares were bought and sold for approximately $21.89 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.78 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 17.45% during the next 3 months and, with a 90% probability hold a price between $3.27 and $4.82 at the end of this 3-month period.

BLRX Signals & Forecast

There are few to no technical positive signals at the moment. The BioLineRx Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.02 and $3.22. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, May 29, 2026, and so far it has fallen -21.16%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for BioLineRx Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.75 and $2.63. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, BioLineRx Ltd. finds support just below today's level at $2.75. If this is broken, then the next support from accumulated volume will be at $2.63 and $2.33.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.170 between high and low, or 5.86%. For the last week the stock has had daily average volatility of 6.06%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BLRX) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect BioLineRx Ltd. to open at $2.98, and during the day (based on 14 day Average True Range), to move between $2.87 and $3.09, which gives a possible trading interval of +/-$0.221 (+/-7.71%) up or down from last closing price. If BioLineRx Ltd. takes out the full calculated possible swing range there will be an estimated 7.71% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $3.01 (1.01%) than the support at $2.75 (7.72%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioLineRx Ltd. stock A Buy?

The BioLineRx Ltd. stock holds several negative signals and despite the positive trend, we believe BioLineRx Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.639 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $2.98 ( 0.113%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BLRX Performance

Trading levels for BLRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 3.15 5.81%
R2 3.09 3.64%
R1 3.05 2.29%
Price 2.98
S1 2.92 -2.06%
S2 2.88 -3.41%
S3 2.81 -5.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.59 20.47%
R2 3.37 13.09%
R1 3.01 1.01%
Price 2.98
S1 2.75 -7.72%
S2 2.63 -11.74%
S3 2.33 -21.81%

FAQ

What is the symbol for BioLineRx Ltd. Stock and on which exchange is it traded?
The symbol for BioLineRx Ltd. is BLRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioLineRx Ltd. Stock?
The BioLineRx Ltd. stock holds several negative signals and despite the positive trend, we believe BioLineRx Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy BioLineRx Ltd. Stock?
BioLineRx Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioLineRx Ltd. Stock.

What's the current price of BioLineRx Ltd. Stock?
As of the end of day on the Jul 16, 2026, the price of an BioLineRx Ltd. (BLRX) share was $2.98.

What is the 52-week high and low for BioLineRx Ltd. Stock?
The 52-week high for BioLineRx Ltd. Stock is $4.74 and the 52-week low is $2.18.

What is the market capitalization of BioLineRx Ltd. Stock?
As of the Jul 16, 2026, the market capitalization of BioLineRx Ltd. is 12.967M.

When is the next earnings date for BioLineRx Ltd.?
The upcoming earnings date for BioLineRx Ltd. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOLINERX LTD.
BioLineRx
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
3.06% Jul 13
SRPT
$17.02
1.23% Jun 29
NMRK
$15.02
5.86% Jun 24
X
XMAX
$8.34
2.28% Jun 24
JLL
$299.78
12.03% Jun 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE